Navigation Links
Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria
Date:10/18/2007

All Children Under 5 in Madagascar to Sleep Under Bed Nets

NEW YORK, Oct. 18 /PRNewswire-USNewswire/ -- Malaria No More and Sumitomo Chemical have teamed up to contribute to the distribution of 1.4 million bed nets to children in Madagascar between October 22-29.

Led by the Malagasy government, the campaign will ensure that virtually every child aged six months to five years old receives a bed net. Sumitomo Chemical donated 110,000 long-lasting insecticide-treated Olyset nets to the distribution. Through the support of Idol Gives Back and The Charity Projects Entertainment Fund, Malaria No More is funding education, distribution, and logistical support associated with the nets. Additional partners in the campaign include the U.S. President's Malaria Initiative, UNICEF, and Red Cross of America and Canada.

Malaria kills more African children than any other disease -- approximately 3,000 every day. It is endemic to 90 percent of Madagascar, where it is the number one cause of death among children. Madagascar's under-5 mortality rate, 124 deaths for every 1,000 live births, is more than 15-times that of the United States.

"Malaria imposes a terrible cost on the lives and livelihoods of people in Madagascar," said Scott Case, COO of Malaria No More. "A $10 long-lasting insecticide-treated bed net is often all it takes to save a child's life."

Sumitomo Chemical's revolutionary Olyset technology has transformed malaria control by incorporating insecticide into the fibers of nets, ensuring that they remain effective for at least five years. Olyset nets are tear-resistant, wash-proof, and never require treatment, making them ideal for difficult-to-reach regions like Madagascar's Central Highlands regions where they will be distributed this week.

"The real test of any bed net is malaria prevention," said Tatsuo Mizuno, General Manager of Vector Control in Sumitomo Chemical's Environmental Health Division. "The extreme durability of Olyset nets will protect the Central Highlands residents for a minimum of five years."

The bed net distribution is part of an integrated Measles Initiative campaign that will also distribute measles and polio vaccines, Vitamin A supplements, and de-worming pills to children. According to a recent UNICEF report, child mortality has reached a record low, dropping below 10 million deaths worldwide (to 9.7 million), down from almost 13 million in 1990. Efforts to combat malaria and measles have played a significant role in that decline.

ABOUT MALARIA NO MORE

Malaria No More's mission is simple: to end deaths due to malaria. The world has known how to beat this disease for more than a century, yet it remains the number one killer of children under five in Africa, claiming more than 1 million lives a year. Malaria No More works to raise the profile of the disease among the public, policymakers, and businesses, while engaging the private sector to provide life-saving bed nets and other critical interventions to families in Africa.

ABOUT SUMITOMO CHEMICAL

Sumitomo Chemical is a multi-national Japanese company, with decades of experience in insecticide manufacturing and plastics technology. Dedicated to solving environmental and social problems through innovative technology and sustainable development, Sumitomo Chemical believes the cycle of poverty can be broken by the prevention of vector-borne diseases. As Olyset has been proven to be the most cost-effective malaria intervention today, Sumitomo Chemical is working to ensure this technology reaches those in need through provision of donated or low-cost nets, and through participation in a 50/50 joint venture for local African manufacture of Olyset.

FOR MORE INFORMATION:

MALARIA NO MORE

Martin Edlund

+1 917 224 3563

martin.edlund@malarianomore.org

SUMITOMO CHEMICAL

Seth Amgott

Office: + 1 212 595 3670

Mobile: + 1 202 415 2625

seth@amgottmitchell.com


'/>"/>
SOURCE Malaria No More
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Feeding channel created by malaria parasite - a new target for malaria treatments
2. Hundred million dollar gift for malaria institute
3. Malaria strikes Munger tribals
4. Sponging Cattle betters spraying in eradicating Malaria
5. Misleading anti-malarial drug
6. Garlic fights malaria and cancer
7. Gene researchers make Malaria-resistant mosquito
8. More Treatment Options For Malaria
9. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
10. New initiative launched to fight malaria by repelling mosquitoes
11. Jharkhand reports 13,000 Malaria cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... MAP ... elevated anxiety levels in people with addiction who are served by MAP’s patient ... biosensing wearable device that monitors heart and breath rates to identify anxiety levels ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) ... Jim Walter Blvd, for an educational and exciting 2-day program. , An attendee ... hearing this before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and ...
(Date:4/24/2017)... ... ... “Reflections of God’s Work”: an enlightening collection of life lessons leading each ... published author, Jerri Broglin, a survivor of great loss who gained insight on how ... for those searching for answers, as we are finding the answers that are so ...
(Date:4/24/2017)... Gainesville, Florida (PRWEB) , ... April 24, 2017 , ... ... at the University of Florida. The event will be held at 7:30 pm on ... and Ken Block and Drew Copeland of Sister Hazel, will support the UF Collegiate ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is a place where ... in my Art and Music. These are created as Metaphysical Transformations where music, which ... mystery culminate to the ultimate singularity.", -- Karen Salicath Jamali , Karen will also ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology: